|
⚲
|
| Keyboard |
| Mark Foletta | |
|---|---|
| Firm | |
| Address | c/o Viacyte, Inc 3550 General Atomics Court San Diego, CA 92121 |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM |
|---|---|---|---|---|---|
| Viacyte Inc | 021-396782 | Director | 53.9 M of 58.5 M |
||
| Viacyte Inc | 021-364188 | Director | 32.6 M of 36.0 M |
||
| Viacyte Inc | 021-327013 | Director | 35.8 M of 90.0 M |
||
| Tocagen Inc | 021-275725 | Executive Officer | 10.9 M of 13.0 M |
||
| Dexcom Inc | 021-263377 | Director | 7.2 M of 7.2 M |
||
| Biocept Inc | 021-253697 | Executive Officer | 1.0 M of 15.0 M |
||
| Viacyte Inc | 021-223406 | Director | 15.0 M of 15.0 M |
||
| Regulus Therapeutics Inc | 021-211442 | Director | 10.0 M of 10.0 M |
||